메뉴 건너뛰기




Volumn 82, Issue 4, 1999, Pages 569-573

Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; OVALBUMIN; RECOMBINANT INTERLEUKIN 2; VIRUS VECTOR;

EID: 0032855661     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990812)82:4<569::AID-IJC16>3.0.CO;2-M     Document Type: Article
Times cited : (14)

References (24)
  • 3
    • 0022546602 scopus 로고
    • Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells
    • CHEEVER, M.A., THOMPSON, D.B., KLARNET, J.P. and GREENBERG, P.D., Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells. J. exp. Med., 163, 1100-1112 (1986).
    • (1986) J. Exp. Med. , vol.163 , pp. 1100-1112
    • Cheever, M.A.1    Thompson, D.B.2    Klarnet, J.P.3    Greenberg, P.D.4
  • 4
    • 0027996540 scopus 로고
    • Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte macrophage colony-stimulating factor
    • CHEN, T.T., TAO, M.H. and LEVY, R., Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte macrophage colony-stimulating factor. J. Immunol., 153, 4775-4787 (1994).
    • (1994) J. Immunol. , vol.153 , pp. 4775-4787
    • Chen, T.T.1    Tao, M.H.2    Levy, R.3
  • 6
    • 0029919272 scopus 로고    scopus 로고
    • Immunotherapy of cancer with genetically modified tumor vaccines
    • GILBOA, E., Immunotherapy of cancer with genetically modified tumor vaccines. Semin. Oncol., 23, 101-107 (1996).
    • (1996) Semin. Oncol. , vol.23 , pp. 101-107
    • Gilboa, E.1
  • 7
    • 0027598183 scopus 로고
    • Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins
    • GILLIES, S.D., YOUNG, D., Lo, K.M. and ROBERTS, S., Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins. Bioconj. Chem., 4, 230-235 (1993).
    • (1993) Bioconj. Chem. , vol.4 , pp. 230-235
    • Gillies, S.D.1    Young, D.2    Lo, K.M.3    Roberts, S.4
  • 8
    • 0021686808 scopus 로고
    • Treatment of disseminated leukemia with cyclophosphamide and immune cells: Tumor immunity reflects long-term persistence of tumor specific donor cells
    • GREENBERG, P.D. and CHEEVER, M.A., Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor specific donor cells. J. Immunol., 133, 3401-3407 (1984).
    • (1984) J. Immunol. , vol.133 , pp. 3401-3407
    • Greenberg, P.D.1    Cheever, M.A.2
  • 9
    • 0031439719 scopus 로고    scopus 로고
    • Human tumor antigens recognized by T-cells
    • KAWAKAMI, Y. and ROSENBERG, S.A., Human tumor antigens recognized by T-cells. Immunol. Res., 16, 313-339 (1997).
    • (1997) Immunol. Res. , vol.16 , pp. 313-339
    • Kawakami, Y.1    Rosenberg, S.A.2
  • 10
    • 0342636415 scopus 로고
    • Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma
    • KIM, T.S. and COHEN, E.P., Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma. Cancer Res., 54, 2531-2535 (1994).
    • (1994) Cancer Res. , vol.54 , pp. 2531-2535
    • Kim, T.S.1    Cohen, E.P.2
  • 11
    • 0031134912 scopus 로고    scopus 로고
    • An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production
    • KIM, T.S., DEKRUYFF, R.H., RUPPER, R., MAECKER, H.T., LEVY, S. and UMETSU, D.T., An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J. Immunol., 158, 4137-4144 (1997).
    • (1997) J. Immunol. , vol.158 , pp. 4137-4144
    • Kim, T.S.1    Dekruyff, R.H.2    Rupper, R.3    Maecker, H.T.4    Levy, S.5    Umetsu, D.T.6
  • 12
    • 0027437513 scopus 로고
    • Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma
    • KIM, T.S., RUSSELL, S.J., COLLINS, M.K.L. and COHEN, E.P., Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma. Int. J. Cancer, 55, 865-872 (1993).
    • (1993) Int. J. Cancer , vol.55 , pp. 865-872
    • Kim, T.S.1    Russell, S.J.2    Collins, M.K.L.3    Cohen, E.P.4
  • 13
    • 0028981435 scopus 로고
    • Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma
    • KIM, T.S., XU, W.S., SUN, T. and COHEN, E.P., Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma. Melanoma Res., 5, 217-227 (1995).
    • (1995) Melanoma Res. , vol.5 , pp. 217-227
    • Kim, T.S.1    Xu, W.S.2    Sun, T.3    Cohen, E.P.4
  • 14
    • 0026015202 scopus 로고
    • The immunotherapy of human cancer with interleukin 2: Present status and future directions
    • KOLITZ, J.E. and MERTELSMANN, R., The immunotherapy of human cancer with interleukin 2: present status and future directions. Cancer Invest., 9, 529-542 (1991).
    • (1991) Cancer Invest. , vol.9 , pp. 529-542
    • Kolitz, J.E.1    Mertelsmann, R.2
  • 15
    • 0031805796 scopus 로고    scopus 로고
    • Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct
    • LIM, Y.S., KANG, B.Y., KIM, E.J., KIM, S.H., HWANG, S.Y. and KIM, T.S., Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct. Immunology, 94, 135-141 (1998).
    • (1998) Immunology , vol.94 , pp. 135-141
    • Lim, Y.S.1    Kang, B.Y.2    Kim, E.J.3    Kim, S.H.4    Hwang, S.Y.5    Kim, T.S.6
  • 17
    • 0020047427 scopus 로고
    • Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor dependent on elimination of tumor-induced suppressor cells
    • NORTH, R.J., Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor dependent on elimination of tumor-induced suppressor cells. J. exp. Med., 155, 1063-1074 (1982).
    • (1982) J. Exp. Med. , vol.155 , pp. 1063-1074
    • North, R.J.1
  • 18
    • 0024490846 scopus 로고
    • Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia
    • PEACE, D.J. and CHEEVER, M.A., Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia. J. exp. Med., 161, 161-173 (1989).
    • (1989) J. Exp. Med. , vol.161 , pp. 161-173
    • Peace, D.J.1    Cheever, M.A.2
  • 20
    • 0031424935 scopus 로고    scopus 로고
    • Keynote address: Perspectives on the use of interleukin-2 in cancer treatment
    • ROSENBERG, S.A., Keynote address: perspectives on the use of interleukin-2 in cancer treatment. Cancer J. sci. Amer., 3, S2-S6 (1997).
    • (1997) Cancer J. Sci. Amer. , vol.3
    • Rosenberg, S.A.1
  • 22
    • 0024264288 scopus 로고
    • Acute immunologic effects of interleukin-2 therapy in cancer patients: Decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens
    • WIEBKE, E.A., ROSENBERG, S.A. and LOTZE, M.T., Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens. J. clin. Oncol., 6, 1440-1449 (1988).
    • (1988) J. Clin. Oncol. , vol.6 , pp. 1440-1449
    • Wiebke, E.A.1    Rosenberg, S.A.2    Lotze, M.T.3
  • 23
    • 0032170538 scopus 로고    scopus 로고
    • Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases
    • XIANG, R., LODE, H.N., DREIER, T., GILLIES, S.D. and REISFELD, R.A., Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases. Cancer Res., 58, 3918-3925 (1998).
    • (1998) Cancer Res. , vol.58 , pp. 3918-3925
    • Xiang, R.1    Lode, H.N.2    Dreier, T.3    Gillies, S.D.4    Reisfeld, R.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.